Experts have warned that the race to produce a Covid-19 vaccine could make the pandemic worse in the long run. A weak or partially effective candidate could potentially result in people believing they are immune to the virus, resulting in higher rates of infection.
That warning was recently voiced by Professor Richard Peto of Oxford University and an adviser to the World Health Organization, who said that the first vaccine would be distributed all over the world, even if it had low efficacy.
According to a global market research by Ipsos MORI, 97 percent of people in China would take a vaccine if it were available, along with 88 percent in Brazil, 87 percent in India and 85 percent in the UK.
Russia recently announced that it was aiming to bring its Sputnik V vaccine to the market at some stage this month, despite the fact that it did not undergo large-scale testing. Only 54 percent of Russians say they would take a vaccine if it were available, with the share of people in France also low at 59 percent. In both Germany and the United States, 67 percent of respondents say they would agree to take a vaccine.